These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2862891)

  • 41. The offset of beta-adrenoceptor antagonism of the responses of the rat right ventricle to isoprenaline.
    Doggrell SA; Henderson CJ
    J Auton Pharmacol; 1998 Oct; 18(5):263-9. PubMed ID: 9831226
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Duration of action and plasma levels of beta-adrenoceptor blocking drugs.
    Aellig WH
    Arch Int Pharmacodyn Ther; 1980; Suppl():32-7. PubMed ID: 6106456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bopindolol and its metabolite 18-502 attenuate regional myocardial acidosis during partial occlusion of the coronary artery in dogs.
    Abiko Y; Gotoh H; Yokoyama T; Abiko T; Hashizume H; Akiyama K
    Arch Int Pharmacodyn Ther; 1994; 327(1):40-55. PubMed ID: 7944827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interindividual variation of beta-adrenoceptor blocking drugs, plasma concentration and effect: influence of genetic status on behaviour of atenolol, bopindolol and metoprolol.
    Dayer P; Leemann T; Marmy A; Rosenthaler J
    Eur J Clin Pharmacol; 1985; 28(2):149-53. PubMed ID: 2859203
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Further evidence for differences between cardiac atypical beta-adrenoceptors and brown adipose tissue beta3-adrenoceptors in the pithed rat.
    Malinowska B; Schlicker E
    Br J Pharmacol; 1997 Dec; 122(7):1307-14. PubMed ID: 9421276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute and long-term antihypertensive effect of bopindolol--a nonselective beta-adrenergic blocker with ISA.
    Andersson OK; Hedner T; Nyberg G
    Eur J Clin Pharmacol; 1985; 29(3):281-5. PubMed ID: 2866965
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Arnold JM; O'Connor PC; Riddell JG; Harron DW; Shanks RG; McDevitt DG
    Br J Clin Pharmacol; 1985 May; 19(5):619-30. PubMed ID: 2860915
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bopindolol, a new long-acting beta-adrenoceptor antagonist--a randomized comparison against propranolol in hypertensive patients.
    Kirch W; Axthelm T
    Int J Clin Pharmacol Res; 1983; 3(2):89-93. PubMed ID: 6148312
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epinephrine-induced enhancement of sympathetic activity in humans: inhibition by nonselective as well as beta 1-selective beta-adrenoceptor blockade.
    van den Meiracker AH; Man in 't Veld AJ; Boomsma F; Blankestijn PJ; Schalekamp MA
    J Cardiovasc Pharmacol; 1990 Apr; 15(4):610-7. PubMed ID: 1691392
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the acute haemodynamic effects of bopindolol and propranolol at rest and during supine exercise.
    Fitscha P; Meisner W; Tiso B
    Eur J Clin Pharmacol; 1988; 34(4):359-62. PubMed ID: 2900143
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bopindolol: Czechoslovak experience with a new beta blocker in the treatment of hypertension.
    Widimský J; Lefflerová K; Dvorák I; Fedelesová V; Lupínek Z; Mayer O; Pinterová E
    Am J Cardiol; 1991 Apr; 67(10):36B-42B. PubMed ID: 1673580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antihypertensive efficacy of the new long-acting beta-blocker bopindolol as related to age.
    Hulthén UL; van Brummelen P; Amann FW; Bühler FR
    J Cardiovasc Pharmacol; 1983; 5(3):426-9. PubMed ID: 6191141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activity and duration of action of pindolol and alprenolol compared in healthy volunteers.
    Aellig WH
    Eur J Clin Pharmacol; 1978 Dec; 14(5):305-8. PubMed ID: 729623
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute and long-term antihypertensive effect of bopindolol once daily or once weekly.
    Andersson O; Hedner T; Nyberg G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S74-6. PubMed ID: 2439826
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bopindolol for the treatment of chronic stable angina pectoris--a clinical study of the relationship between dose and effect.
    Holmes D; Fryda-Kaurimsky Z; Krueger K
    Cardiology; 1990; 77(6):459-65. PubMed ID: 1981493
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Withdrawal phenomena after atenolol and bopindolol: hormonal changes in normal volunteers.
    Walden RJ; Tomlinson B; Graham B; Smith C; Betteridge DJ; Prichard BN
    Br J Clin Pharmacol; 1990 Oct; 30(4):547-56. PubMed ID: 1981317
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dose-finding study with bopindolol in arterial hypertension.
    Willimann P; Peter R; Siegenthaler H
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S25-9. PubMed ID: 2439814
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Double-blind comparison of once-daily bopindolol and atenolol for mild-to-moderate hypertension.
    Colnago R; Meregalli M; Turri D; Nazzari M; Fiorella G; Guffanti EE; Mazzola C
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):347-52. PubMed ID: 2887520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.
    Leopold G; Ungethüm W; Pabst J; Simane Z; Bühring KU; Wiemann H
    Br J Clin Pharmacol; 1986 Sep; 22(3):293-300. PubMed ID: 2876722
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiovascular beta-adrenergic blocking effects of bornaprolol in humans: relation to dose and plasma concentration.
    Cheymol G; Jaillon P; Lecoq B; Lecoq V; Cheymol A; Krumenacker M
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):694-8. PubMed ID: 2442536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.